A Randomised Controlled Trial of Bisphosphonate Therapy in Osteonecrosis of the Hip.

Trial Profile

A Randomised Controlled Trial of Bisphosphonate Therapy in Osteonecrosis of the Hip.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Femur head necrosis
  • Focus Therapeutic Use
  • Acronyms BONES
  • Most Recent Events

    • 17 Jan 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 26 Mar 2010 Alendronate deleted as drug descriptor as reported by ClinicalTrials.gov.
    • 26 Mar 2010 Planned number of patients changed from 150 to 120 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top